Search

The project aims to develop a life support system for long duration manned human missions

The event was attended by Teresa Riesgo, Secretary General for Innovation, and Ana Polanco, President of the association. The analysis highlights that 60% of the people working in companies in the

AptaTargets has obtained priority medicines (PRIME) designation from the European Medicines Agency (EMA) for the neuroprotectant ApTOLL to improve the treatment of acute ischemic stroke, which

The Lifetime Achievement award is given to a startup and a spinoff that have been supported by the regional programme for the Creation of new companies, monitored by Beaz over the last five years.

Their incorporation into Almirall's R&D facilities is the first step in Almirall's plans to create a highly collaborative environment for researchers from biotech, start-ups, academia, as well as

ISDE has recognised Polanco for her contribution to transforming the growth model through the biotechnology industry

Barcelona Science Park (PCB) has refinanced the €36.7 M debt due with the Ministry of Science and Innovation over 25 years thanks to the support of the Government of Catalonia and the University of

El lunes 20 de febrero, la compañía fue galardonada con el premio “Empresa Novel”, dentro de la entrega Premios Euskadi Avanza, y organizados por el periódico local de mayor importancia El Correo y el

Oryzon Genomics, announced today that it will host a virtual panel discussion, featuring Dr. Dyanna Phillips Domilici (Adams Clinical & Copley Clinical), Dr. med. Peter Hahn (Investigator & Neurology

Meet CEISA, our new member. We talked to Josep Tascón, CEO of the company.

BCN HEALTH ha publicado el estudio 'Economic implications of endometriosis: A review' en la revista 'PharmacoEconomics'

Strong clinical progress in both oncology and CNS

The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the

Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an alternative to conventional antibiotics

Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund in 2018. Other Investors include the European Investment Fund and Alantra

For International Day of Women and Girls in Science, 14 women from 12 companies will host young female students to encourage them to go into science and innovation and show them the different

ApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in acute ischemic stroke trials, decreasing significantly mortality and long-term functional disability

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today

BCN HEALTH ha publicado el estudio 'Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care' en la revista 'Expert Review of Pharmacoeconomics & Outcomes

Amadix, IOMED and NorayBio have joined forces to develop a predictive algorithm for mass data analysis to reduce the mortality rate of this disease

The “Instituto de Investigación Biomédica de Córdoba” hosts the event, supported by “Instituto de Salud Carlos III (ISCIII)”, with the sponsorship of “Universidad Carlos III de Madrid”, Cidi Salud and